Antitumor activity of a PPARdelta antagonist.
Elikkottil
Jaseena
J
Vascular Biology Center, Division of Hematology Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Kohli
Divyanshoo R
DR
Gupta
Kalpna
K
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D008954:Models, Biological; D047494:PPAR delta / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism
D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D047494:PPAR delta